Clik here to view.
TearLab posts 28% increase in Q1 revenue
TearLab (NASDAQ:TEAR; TSX:TLB) reported first quarter net revenue of $5.4-million, up 28% from $4.2-million for the same period in 2014. TearLab Osmolarity System A total of 261 orders for TearLab...
View ArticleClik here to view.
TearLab names Wes Brazell as CFO
TearLab (NASDAQ:TEAR; TSX:TLB) has appointed Wes Brazell as CFO, with overall responsibility for operational finance, financial reporting, budgeting and strategic planning, as well as helping to manage...
View ArticleClik here to view.
Doctors discuss importance of tear film osmolarity
In an Eyetube.net video segment of the CRST Journal Club (Cataract & Refractive Surgery Today), Dr. John Davidson, of Miramar Eye Specialists in Ventura County, CA, and Dr. Jay Pepose, of the...
View ArticleClik here to view.
TearLab Q2 revenue climbs 27%
TearLab (NASDAQ:TEAR; TSX:TLB) has reported net revenue of $6.3-million for the second quarter this year, up 27%, from $5-million a year ago. A total of 394 orders for TearLab systems were booked in...
View ArticleClik here to view.
Roth ups TearLab price target to $4
Roth Capital Partners has raised its price target for TearLab (NASDAQ:TEAR; TSX:TLB) to $4 from $3 after the company posted a 27% jump in second quarter revenue. The stock closed at $2.48 on Friday....
View ArticleClik here to view.
TearLab Q3 revenue climbs 27%
Third quarter revenue for TearLab (NASDAQ:TEAR; TSX:TLB) rose 27% to $6.6-million from $5.2-million a year ago. A net total of 228 TearLab systems were added in the third quarter. “We delivered a...
View ArticleClik here to view.
TearLab estimates Q4 revenue rose 28%
TearLab (NASDAQ:TEAR; TSX:TLB) expects to report revenue of approximately $6.8-million for the fourth quarter of 2015, up about 28% from the same quarter in 2014. In addition, TearLab estimated that a...
View ArticleClik here to view.
TearLab forecasts 25% jump in Q1 revenue
TearLab (NASDAQ:TEAR; TSX:TLB) estimates revenue for the first quarter this year will be about $6.8-million, reflecting a 25% increase from the first quarter of 2015. In addition, TearLab estimates...
View ArticleClik here to view.
TearLab prices $17.3-million registered public offering
TearLab (NASDAQ:TEAR; TSX:TLB) has priced a public offering of common stock to raised gross proceeds of approximately $17.3-million to close on May 9. The offering was priced at 75 cents a share of...
View ArticleClik here to view.
TearLab Q1 revenue climbs 25%
First quarter revenue for TearLab (NASDAQ:TEAR; TSX:TLB) rose 25% to $6.8-million from $5.4-million a year ago. A net total of 257 TearLab Osmolarity Systems were added in the first quarter of 2016, of...
View Article
